SPARK Reach - Seminar

| 04:00 PM - 05:00 PM

Developing your molecules to initiate Phase I clinical trials

The CU Anschutz Gates Biomanufacturing Facility is here to help! 

Presented by Matt Seefeldt 

Executive Director, Charles C. Gates Biomanufacturing Facility

Initiating human Phase I clinical trials requires developing a scalable and compliant Good Manufacturing Process (GMP).  We’ll review the basis for process design, a summary of FDA regulatory requirements, and the workplan required for generating process data to support an Investigational New Drug (IND) application.  We’ll highlight the mission and capabilities of the Gates Biomanufacturing Facility to translate therapies on campus. 


Add event to: